Laws SM - Search Results

1

Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.

Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN; AIBL Research Group. Gupta VB, et al. Among authors: laws sm. Neurology. 2011 Mar 22;76(12):1091-8. doi: 10.1212/WNL.0b013e318211c352. Neurology. 2011. PMID: 21422459

2

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.

Laws SM, Taddei K, Martins G, Paton A, Fisher C, Clarnette R, Hallmayer J, Brooks WS, Gandy SE, Martins RN. Laws SM, et al. Neuroreport. 1999 Mar 17;10(4):879-82. doi: 10.1097/00001756-199903170-00038. Neuroreport. 1999. PMID: 10208564 Clinical Trial.

3

Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment.

Laws SM, Clarnette RM, Taddei K, Martins G, Paton A, Almeida OP, Förstl H, Martins RN. Laws SM, et al. Neurobiol Aging. 2002 Jan-Feb;23(1):55-8. doi: 10.1016/s0197-4580(01)00254-8. Neurobiol Aging. 2002. PMID: 11755019

4

APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.

Laws SM, Clarnette RM, Taddei K, Martins G, Paton A, Hallmayer J, Almeida OP, Groth DM, Gandy SE, Förstl H, Martins RN. Laws SM, et al. Mol Psychiatry. 2002;7(7):768-75. doi: 10.1038/sj.mp.4001083. Mol Psychiatry. 2002. PMID: 12192621

5

Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.

Taddei K, Fisher C, Laws SM, Martins G, Paton A, Clarnette RM, Chung C, Brooks WS, Hallmayer J, Miklossy J, Relkin N, St George-Hyslop PH, Gandy SE, Martins RN. Taddei K, et al. Among authors: laws sm. Mol Psychiatry. 2002;7(7):776-81. doi: 10.1038/sj.mp.4001072. Mol Psychiatry. 2002. PMID: 12192622

6

Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Laws SM, et al. Mol Psychiatry. 2002;7(8):886-90. doi: 10.1038/sj.mp.4001097. Mol Psychiatry. 2002. PMID: 12232782

7

Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women.

Dick IM, Devine A, Marangou A, Dhaliwal SS, Laws S, Martins RN, Prince RL. Dick IM, et al. Bone. 2002 Oct;31(4):497-502. doi: 10.1016/s8756-3282(02)00851-7. Bone. 2002. PMID: 12398946

8

Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Laws SM, Hone E, Gandy S, Martins RN. Laws SM, et al. J Neurochem. 2003 Mar;84(6):1215-36. doi: 10.1046/j.1471-4159.2003.01615.x. J Neurochem. 2003. PMID: 12614323 Free article. Review.

9

Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.

Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Thomas EA, et al. Among authors: laws sm. Biol Psychiatry. 2003 Jul 15;54(2):136-41. doi: 10.1016/s0006-3223(02)01976-5. Biol Psychiatry. 2003. PMID: 12873803

10

Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia.

Dean B, Laws SM, Hone E, Taddei K, Scarr E, Thomas EA, Harper C, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN. Dean B, et al. Among authors: laws sm. Biol Psychiatry. 2003 Sep 15;54(6):616-22. doi: 10.1016/s0006-3223(03)00075-1. Biol Psychiatry. 2003. PMID: 13129656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters